Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other. [GOC:mah]
Negative regulation of monoatomic ion transmembrane transport involves a complex interplay of cellular mechanisms that tightly control the movement of single-atom ions across cell membranes. This process is essential for maintaining cellular homeostasis, regulating cell volume, and enabling critical physiological functions such as nerve impulse transmission, muscle contraction, and nutrient uptake. Here's a detailed breakdown:
**1. Ion Channels and Transporters:**
- **Ion Channels:** These proteins form pores in the cell membrane, allowing specific ions to passively move down their electrochemical gradients. Examples include sodium (Na+) channels, potassium (K+) channels, and calcium (Ca2+) channels.
- **Transporters:** These proteins actively move ions against their concentration gradient, requiring energy. Examples include the sodium-potassium pump (Na+/K+ ATPase), which pumps Na+ out of the cell and K+ into the cell.
**2. Regulatory Mechanisms:**
- **Voltage-Gated Channels:** These channels open or close in response to changes in membrane potential. This mechanism is crucial for nerve impulse propagation and muscle contraction.
- **Ligand-Gated Channels:** These channels open or close in response to the binding of a specific molecule, such as a neurotransmitter. This mechanism allows for rapid and specific signaling between cells.
- **Phosphorylation and Dephosphorylation:** The addition or removal of a phosphate group can alter the conformation and activity of ion channels and transporters, regulating their function.
- **Second Messenger Systems:** These systems involve intracellular signaling molecules that amplify and modulate ion channel activity. For instance, the cyclic AMP (cAMP) signaling pathway can regulate the opening of specific ion channels.
- **Membrane Potential:** The electrical potential difference across the cell membrane can influence the opening and closing of voltage-gated channels, further regulating ion transport.
**3. Importance of Negative Regulation:**
- **Maintaining Homeostasis:** Negative regulation ensures that ion concentrations within cells are kept within narrow ranges, essential for cell survival.
- **Preventing Overstimulation:** In the case of nerve impulses, negative regulation prevents excessive signaling and ensures proper signal transmission.
- **Controlling Cellular Volume:** Ion transport plays a critical role in regulating cell volume. Negative regulation helps prevent swelling or shrinking of cells.
**4. Examples of Negative Regulation:**
- **Inactivation of Ion Channels:** Many ion channels have built-in mechanisms that lead to their inactivation after they open, preventing excessive ion flow.
- **Downregulation of Transporter Expression:** The number of ion transporters present in the cell membrane can be decreased, reducing ion transport capacity.
- **Blockage of Ion Channels:** Certain molecules can bind to and block ion channels, preventing ion flow.
**In summary, negative regulation of monoatomic ion transmembrane transport is a multifaceted process involving a complex interplay of ion channels, transporters, and various regulatory mechanisms. It is essential for maintaining cellular homeostasis, ensuring proper signaling, and controlling cell volume. Understanding these intricate processes is crucial for understanding various physiological functions and for developing therapeutic strategies for ion channel-related diseases.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein cereblon | A protein cereblon that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96SW2] | Homo sapiens (human) |
14-3-3 protein theta | A 14-3-3 protein theta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P27348] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dimethyl sulfoxide | dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents. Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
uracil | 2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder | pyrimidine nucleobase; pyrimidone | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite |
rolipram | pyrrolidin-2-ones | antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor | |
thalidomide | 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group. thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide. Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. | phthalimides; piperidones | |
uridine | uridines | drug metabolite; fundamental metabolite; human metabolite | |
uridine monophosphate | uridine 5'-monophosphate : A pyrimidine ribonucleoside 5'-monophosphate having uracil as the nucleobase. Uridine Monophosphate: 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. | pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite |
dimethyl sulfone | sulfone | ||
hydantoins | Hydantoins: Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS. imidazolidine-2,4-dione : An imidazolidinone with oxo groups at position 2 and 4. | imidazolidine-2,4-dione | |
succinimide | succinimide : A dicarboximide that is pyrrolidine which is substituted by oxo groups at positions 2 and 5. succinimide: RN given refers to parent cpd | dicarboximide; pyrrolidinone | |
1-methyluracil | 1-methyluracil : A pyrimidone that is uracil with a methyl group substituent at position 1. 1-methyluracil: RN given refers to parent cpd; structure | nucleobase analogue; pyrimidone | metabolite |
1-methylhydantoin | 1-methylhydantoin: structure in first source | imidazolidine-2,4-dione | bacterial metabolite |
glutarimide | dicarboximide; piperidones | ||
1-aminohydantoin | 1-aminohydantoin: a metabolite of nitrofurantoin | imidazolidine-2,4-dione | |
n-hydroxysuccinimide | N-hydroxysuccinimide: structure | ||
2-(2,6-dioxopiperidin-3-yl)phthalimidine | 2-(2,6-dioxopiperidin-3-yl)phthalimidine: thalidomide analog; structure; RN given refers to cpd without isomeric designation | ||
peptide elongation factor 2 | (S)-thalidomide : A 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione that has S-configuration at the chiral centre. | 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione | teratogenic agent |
pomalidomide | 3-aminophthalimidoglutarimide: structure in first source | aromatic amine; dicarboximide; isoindoles; piperidones | angiogenesis inhibitor; antineoplastic agent; immunomodulator |
lenalidomide | aromatic amine; dicarboximide; isoindoles; piperidones | angiogenesis inhibitor; antineoplastic agent; immunomodulator | |
thiohydantoins | Thiohydantoins: Sulfur analogs of hydantoins with one or both carbonyl groups replaced by thiocarbonyl groups. | ||
dasatinib | dasatinib (anhydrous) : An aminopyrimidine that is 2-methylpyrimidine which is substituted at position 4 by the primary amino group of 2-amino-1,3-thiazole-5-carboxylic acid and at position 6 by a 4-(2-hydroxyethyl)piperazin-1-yl group, and in which the carboxylic acid group has been formally condensed with 2-chloro-6-methylaniline to afford the corresponding amide. A multi-targeted kinase inhibitor, it is used, particularly as the monohydrate, for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN). N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide: a dasatinib prodrug; structure in first source | 1,3-thiazoles; aminopyrimidine; monocarboxylic acid amide; N-(2-hydroxyethyl)piperazine; N-arylpiperazine; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor |
furagin | furagin : An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [3-(5-nitro-2-furyl)prop-2-en-1-ylidene]amino group (the configuration of the C=C and C=N bonds in the grouping that links the two heterocycles is not specified). A nitrofuran antibiotic with properties similar to nitrofurantoin, furagin is used in the treatment of urinary tract infections. Furagin: Nitrofuran derivative anti-infective agent used for urinary tract infections. | ||
2-acetylfuranonaphthoquinone | 2-acetylfuranonaphthoquinone: has antineoplastic activity; structure in first source | ||
r18 peptide | R18 peptide: a 20-mer peptide, derived from a phage library, that binds 14-3-3 tau protein; amino acid sequence in first source | ||
ponatinib | (trifluoromethyl)benzenes; acetylenic compound; benzamides; imidazopyridazine; N-methylpiperazine | antineoplastic agent; tyrosine kinase inhibitor | |
cc-122 | 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione: a pleiotropic pathway modifier with antineoplastic activity; structure in first source | ||
sofosbuvir | sofosbuvir : A nucleotide conjugate that is used in combination with ledipasvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection. Sofosbuvir: A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C. | isopropyl ester; L-alanyl ester; nucleotide conjugate; organofluorine compound; phosphoramidate ester | antiviral drug; hepatitis C protease inhibitor; prodrug |
jq1 compound | carboxylic ester; organochlorine compound; tert-butyl ester; thienotriazolodiazepine | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; bromodomain-containing protein 4 inhibitor; cardioprotective agent; ferroptosis inducer | |
abt-333 | dasabuvir : A member of the class of pyrimidone, which is (as the monohydrate of its sodium salt) in combination with ombitasvir, paritaprevir and ritonavir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. dasabuvir: an antiviral agent | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor |
epz-6438 | tazemetostat: a histone methyltransferase EZH2 inhibitor with antineoplastic activity | ||
MZ1 | organic molecular entity |